Literature DB >> 33758788

Sex differences in the blood-brain barrier and neurodegenerative diseases.

Callie M Weber1, Alisa Morss Clyne1.   

Abstract

The number of people diagnosed with neurodegenerative diseases is on the rise. Many of these diseases, including Alzheimer's disease, Parkinson's disease, multiple sclerosis, and motor neuron disease, demonstrate clear sexual dimorphisms. While sex as a biological variable must now be included in animal studies, sex is rarely included in in vitro models of human neurodegenerative disease. In this Review, we describe these sex-related differences in neurodegenerative diseases and the blood-brain barrier (BBB), whose dysfunction is linked to neurodegenerative disease development and progression. We explain potential mechanisms by which sex and sex hormones affect BBB integrity. Finally, we summarize current in vitro BBB bioengineered models and highlight their potential to study sex differences in BBB integrity and neurodegenerative disease.
© 2021 Author(s).

Entities:  

Year:  2021        PMID: 33758788      PMCID: PMC7968933          DOI: 10.1063/5.0035610

Source DB:  PubMed          Journal:  APL Bioeng        ISSN: 2473-2877


  171 in total

1.  Culture and characterization of microvascular endothelial cells derived from human brain.

Authors:  K Dorovini-Zis; R Prameya; P D Bowman
Journal:  Lab Invest       Date:  1991-03       Impact factor: 5.662

Review 2.  Estrogen: a master regulator of bioenergetic systems in the brain and body.

Authors:  Jamaica R Rettberg; Jia Yao; Roberta Diaz Brinton
Journal:  Front Neuroendocrinol       Date:  2013-08-29       Impact factor: 8.606

3.  Sex Differences in Circulating Biomarkers of Cardiovascular Disease.

Authors:  Emily S Lau; Samantha M Paniagua; James Sawalla Guseh; Vijeta Bhambhani; Markella V Zanni; Paul Courchesne; Asya Lyass; Martin G Larson; Daniel Levy; Jennifer E Ho
Journal:  J Am Coll Cardiol       Date:  2019-09-24       Impact factor: 24.094

4.  Alzheimer disease in the United States (2010-2050) estimated using the 2010 census.

Authors:  Liesi E Hebert; Jennifer Weuve; Paul A Scherr; Denis A Evans
Journal:  Neurology       Date:  2013-02-06       Impact factor: 9.910

Review 5.  Sex differences in Alzheimer's disease: Understanding the molecular impact.

Authors:  Carlos A Toro; Larry Zhang; Jiqing Cao; Dongming Cai
Journal:  Brain Res       Date:  2019-05-23       Impact factor: 3.252

6.  Estradiol Inhibits Cytokine-Induced Expression of VCAM-1 and ICAM-1 in Cultured Human Endothelial Cells Via AMPK/PPARα Activation.

Authors:  Xuhui Hou; Fei Pei
Journal:  Cell Biochem Biophys       Date:  2015-07       Impact factor: 2.989

7.  Matrix metalloproteinase-9 activity and a downregulated Hedgehog pathway impair blood-brain barrier function in an in vitro model of CNS tuberculosis.

Authors:  Sara Brilha; Catherine W M Ong; Babette Weksler; Nacho Romero; Pierre-Olivier Couraud; Jon S Friedland
Journal:  Sci Rep       Date:  2017-11-22       Impact factor: 4.379

Review 8.  The protective role of estrogen and estrogen receptors in cardiovascular disease and the controversial use of estrogen therapy.

Authors:  Andrea Iorga; Christine M Cunningham; Shayan Moazeni; Gregoire Ruffenach; Soban Umar; Mansoureh Eghbali
Journal:  Biol Sex Differ       Date:  2017-10-24       Impact factor: 5.027

Review 9.  History and progress of hypotheses and clinical trials for Alzheimer's disease.

Authors:  Pei-Pei Liu; Yi Xie; Xiao-Yan Meng; Jian-Sheng Kang
Journal:  Signal Transduct Target Ther       Date:  2019-08-23

10.  Estradiol promotes pentose phosphate pathway addiction and cell survival via reactivation of Akt in mTORC1 hyperactive cells.

Authors:  Y Sun; X Gu; E Zhang; M-A Park; A M Pereira; S Wang; T Morrison; C Li; J Blenis; V H Gerbaudo; E P Henske; J J Yu
Journal:  Cell Death Dis       Date:  2014-05-15       Impact factor: 8.469

View more
  14 in total

1.  Sex differences in plasma p-tau181 associations with Alzheimer's disease biomarkers, cognitive decline, and clinical progression.

Authors:  Amaryllis A Tsiknia; Steven D Edland; Erin E Sundermann; Emilie T Reas; James B Brewer; Douglas Galasko; Sarah J Banks
Journal:  Mol Psychiatry       Date:  2022-06-29       Impact factor: 15.992

Review 2.  Biological determinants impact the neurovascular toxicity of nicotine and tobacco smoke: A pharmacokinetic and pharmacodynamics perspective.

Authors:  Sabrina Rahman Archie; Sejal Sharma; Elizabeth Burks; Thomas Abbruscato
Journal:  Neurotoxicology       Date:  2022-02-09       Impact factor: 4.294

3.  Sex-based disparities in outcome in pediatric acute lymphoblastic leukemia: a Children's Oncology Group report.

Authors:  Sumit Gupta; David T Teachey; Zhiguo Chen; Karen R Rabin; Kimberly P Dunsmore; Eric C Larsen; Kelly W Maloney; Leonard A Mattano; Stuart S Winter; Andrew J Carroll; Nyla A Heerema; Michael J Borowitz; Brent L Wood; William L Carroll; Elizabeth A Raetz; Naomi J Winick; Mignon L Loh; Stephen P Hunger; Meenakshi Devidas
Journal:  Cancer       Date:  2022-02-24       Impact factor: 6.860

4.  Sex-Related Microglial Perturbation Is Related to Mitochondrial Changes in a Model of Alzheimer's Disease.

Authors:  Eoin O'Neill; Virginia Mela; Aline Sayd Gaban; Sibylle Bechet; Aoife McGrath; Aife Walsh; Allison McIntosh; Marina A Lynch
Journal:  Front Cell Neurosci       Date:  2022-07-05       Impact factor: 6.147

5.  Both the Complexity of Tight Junctions and Endothelial Transcytosis Are Increased During BBB Postnatal Development in Rats.

Authors:  Wei Li; Jinlong Zou; Junkui Shang; Chenhao Gao; Ruihua Sun; Ruijie Liu; Huixia Cao; Yanliang Wang; Jiewen Zhang
Journal:  Front Neurosci       Date:  2022-04-28       Impact factor: 5.152

6.  A New Hypothesis for Alzheimer's Disease: The Lipid Invasion Model.

Authors:  Jonathan D'Arcy Rudge
Journal:  J Alzheimers Dis Rep       Date:  2022-03-25

Review 7.  Nanotherapeutics and the Brain.

Authors:  Andrea Joseph; Elizabeth Nance
Journal:  Annu Rev Chem Biomol Eng       Date:  2022-03-23       Impact factor: 9.700

8.  Vascular and blood-brain barrier-related changes underlie stress responses and resilience in female mice and depression in human tissue.

Authors:  Laurence Dion-Albert; Alice Cadoret; Ellen Doney; Fernanda Neutzling Kaufmann; Katarzyna A Dudek; Beatrice Daigle; Lyonna F Parise; Flurin Cathomas; Nalia Samba; Natalie Hudson; Manon Lebel; Matthew Campbell; Gustavo Turecki; Naguib Mechawar; Caroline Menard
Journal:  Nat Commun       Date:  2022-01-10       Impact factor: 14.919

Review 9.  Recent progress and new challenges in modeling of human pluripotent stem cell-derived blood-brain barrier.

Authors:  Li Yan; Rebecca A Moriarty; Kimberly M Stroka
Journal:  Theranostics       Date:  2021-11-02       Impact factor: 11.556

Review 10.  Epigallocatechin-3-Gallate (EGCG): New Therapeutic Perspectives for Neuroprotection, Aging, and Neuroinflammation for the Modern Age.

Authors:  Ashley Payne; Samuel Nahashon; Equar Taka; Getinet M Adinew; Karam F A Soliman
Journal:  Biomolecules       Date:  2022-02-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.